PROC Procaps Group S.A. Quick Ratio

Procaps Group Corp - graphic logo of issuer PROC

Procaps Group S.A. (PROC) generates revenue through B2B contracts for softgel capsule production, ensuring high margins and a steady cash flow. This chart shows the asset value is fixed at 0.00. Ownership of the unique Softgel technology makes the company an indispensable link in the global pharmaceutical supply chain. However, debts within Latin American divisions and reporting delays necessitate strict oversight, as operating profit is approaching a critical minimum.

PROC: Procaps Group SA Intermediate Coverage Ratio 07/04/2022 - 02/16/2025
Finished products of procapsgroup.com

As a CDMO leader in softgel production for global pharma behemoths, Procaps Group S.A. (PROC) relies on high asset turnover. The quick ratio excludes inventory, assessing the company's ability to settle short-term liabilities using only cash and accounts receivable. The stability of this curve confirms the business's solvency without relying on the sale of goods. Excessive growth in this metric would indicate inefficient capital utilization.

Analysis of competing companies

Haleon Group (HLN) - Quick Liquidity|Quick Liquidity Indicator Kenvue Health|VRNA (Verona Pharma plc) - Quick Ratio|Quick Ratio jyongbio.com|Quick Liquidity Indicator LGND (Ligand)|AMRX (Amneal Pharmaceuticals, Inc.) - Intermediate Coverage Ratio|Quick Liquidity Perrigo Company PRGO|Alvotech Biopharmaceuticals (ALVO) - Immediate Liquidity|LQDA: Quick Liquidity Indicator|glpg.com - Intermediate Liquidity Ratio|ANIP: Quick Ratio|MannKind Corp - Intermediate Coverage Ratio|AMPH (Amphastar) - Quick Ratio|Immediate Liquidity Pacira Corp PCRX|Quick Liquidity ARS Pharmaceuticals (SPRY)|TBPH (theravance.com) - Intermediate Coverage Ratio|Quick Liquidity Aquestive Therapeutics, Inc. AQST|SCPH (scPharmaceuticals, Inc.) - Critical Liquidity Ratio|TECX - Quick Liquidity|Intermediate Coverage Ratio TNXP (Tonix Pharmaceuticals Holding)|sxtchina.com (SXTC) - Quick Liquidity|Immediate Liquidity Eupraxia Pharmaceuticals Inc. (EPRX)|BHST (BioHarvest Sciences Inc.) - Quick Ratio|Quick Liquidity Indicator Invizyne Technologies (EXOZ)|Quick Ratio ORMP|Quick Ratio enterabio.com (ENTX)|Quick Liquidity MindWalk Holdings HYFT|ABVC (abvcpharma.com) - Critical Liquidity Ratio|CPIX - Quick Liquidity|Interim Coverage Ratio Quantum BioPharma Ltd. QNTM|FGEN (FibroGen Corp) - Quick Liquidity Indicator|Telomir Pharmaceuticals Corp - Intermediate Coverage Ratio|RANI (Rani Therapeutics Holdings) - Quick Ratio|SNYR - Critical Liquidity|Quick Liquidity Rallybio Corporation (RLYB)|LEXX (lexariabioscience.com) - Intermediate Coverage Ratio|Quick Liquidity Pulmatrix Corp PULM|Pheton Holdings Limited (PTHL) - Immediate Liquidity|APM: Quick Liquidity Indicator|LYRA - Quick Ratio|Impact BioMedical Inc (IBO) - Quick Liquidity|Critical Liquidity Ratio TNFA (TNF Pharmaceuticals, Inc.)|Quick Liquidity Indicator YCBD|PRFX: Intermediate Coverage Ratio|Quick Liquidity Altamira Therapeutics (CYTO)|Interim Coverage Ratio lipella.com|OptiNose - Quick Liquidity Indicator|Interim Coverage Ratio Pieris Pharmaceuticals Inc (PIRS)|Petros - Quick Ratio|QLI - Quick Ratio|SLRN (Acelyrin, Inc.) - Quick Liquidity Indicator|TFFP - Interim Coverage Ratio